Health Care Reform: The Impact on Life Sciences Companies

Recently enacted health care reform legislation presents life sciences companies with many business challenges and opportunities. This program will provide a roadmap to navigate through the new legal requirements and issues that will affect companies, as well as provide information and guidance about how to access federal funds and influence the regulatory implementation process.

Program Topics:

• Therapeutic Discovery Project Credit
• Insurance market changes
• Comparative effectiveness
• Cures Acceleration Network
• Biosimilars
• New industry taxes and fees
• Physician Sunshine Act

Presenters:

• Michael M. Gaba | Healthcare & Life Sciences Federal Policy Team Leader
• Michael J. Werner | Healthcare & Life Sciences Partner
• Jennifer A. Short | Litigation Partner
• Lisa Tofil | Healthcare & Life Sciences Partner
• Jeff Mittleman | Healthcare & Life Sciences Partner